Evaluation of testosterone and prolactin hormones levels in erectile dysfunction patients after single oral dose of Tadalafil
Erectile dysfunction (ED) is defined as a consistent inability to sustain an erection sufficient for sexual intercourse. Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release...
Saved in:
Main Author: | Hayder Hamed Abed (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy / Mustansiriyah University,
2008-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tadalafil in the treatment of erectile dysfunction
by: Robert M Coward, et al.
Published: (2008) -
A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
by: Samuel L Washington III, et al.
Published: (2010) -
Evaluation of Lipid Profile as Indicators for Patients with Erectile Dysfunction
by: Hayder Hamed Abed, et al.
Published: (2011) -
Tadalafil Once a Day for Men with Erectile Dysfunction: Is It Superior than On-Demand Administration?
by: Dimas Tri Prasetyo, et al.
Published: (2019) -
Anterior ischemic optic neuropathy in a patient with erectile dysfunction: Tadalafil as an offending medication
by: Alireza Dehghani, et al.
Published: (2018)